一、中国医药市场概况中国是世界上发展最快、人口最多的国家,中国的医药市场也是世界上发展最快的医药市场之一。自从2001年中国加入世界贸易组织之后,经济的全球化对中国的医药产业带来了巨大的挑战,同样对投资于中国的外资医药企业产生了深远的影响。中国社会正在快速的老龄化,2006年中国65岁以上的老年人口达到了1.04亿人,预计到2050年将会增加到3.32亿人。由于老年人的 I. Overview of China’s pharmaceutical market China is the fastest growing and most populous country in the world. China’s pharmaceutical market is also one of the fastest growing pharmaceutical markets in the world. Since China’s accession to the World Trade Organization in 2001, the globalization of the economy has brought tremendous challenges to China’s pharmaceutical industry and has also had a profound impact on foreign-invested pharmaceutical companies investing in China. Chinese society is rapidly aging. In 2006, the number of elderly people over 65 in China reached 104 million, and it is expected to increase to 332 million by 2050. Due to the elderly